John R. North

1.4k total citations
35 papers, 1.1k citations indexed

About

John R. North is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, John R. North has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in John R. North's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Viral-associated cancers and disorders (6 papers) and Photodynamic Therapy Research Studies (5 papers). John R. North is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Viral-associated cancers and disorders (6 papers) and Photodynamic Therapy Research Studies (5 papers). John R. North collaborates with scholars based in United Kingdom, United States and Canada. John R. North's co-authors include M. A. Epstein, Andrew Morgan, Oreola Donini, B. Brett Finlay, Brigitte A. Askonas, M. Marta Guarna, Robert E. W. Hancock, Monisha G. Scott, Yuexin Li and Edie Dullaghan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

John R. North

34 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John R. North United Kingdom	17	341	336	318	190	174	35	1.1k
Kazuhisa Sugimura Japan	21	346 1.0×	541 1.6×	142 0.4×	121 0.6×	147 0.8×	79	1.2k
Gregor S. D. Reid Canada	26	960 2.8×	707 2.1×	340 1.1×	145 0.8×	294 1.7×	71	2.1k
Dong Soo Yu South Korea	26	790 2.3×	660 2.0×	159 0.5×	189 1.0×	328 1.9×	98	1.8k
Katharina F. Kubatzky Germany	20	342 1.0×	567 1.7×	178 0.6×	78 0.4×	255 1.5×	45	1.3k
M.J. Levine United States	20	203 0.6×	1.0k 3.1×	258 0.8×	81 0.4×	121 0.7×	37	1.9k
Theodora Fifis Australia	18	568 1.7×	629 1.9×	185 0.6×	474 2.5×	186 1.1×	38	1.5k
Christian Kleist Germany	22	342 1.0×	511 1.5×	154 0.5×	66 0.3×	456 2.6×	56	1.3k
Romela Irene Ramos United States	17	631 1.9×	503 1.5×	149 0.5×	136 0.7×	150 0.9×	27	1.4k
Colleen Olive Australia	22	681 2.0×	620 1.8×	168 0.5×	192 1.0×	90 0.5×	54	1.5k
Takashi Hirano Japan	22	324 1.0×	148 0.4×	263 0.8×	359 1.9×	47 0.3×	95	1.1k

Countries citing papers authored by John R. North

Since Specialization

Citations

This map shows the geographic impact of John R. North's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. North with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. North more than expected).

Fields of papers citing papers by John R. North

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. North. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. North. The network helps show where John R. North may publish in the future.

Co-authorship network of co-authors of John R. North

This figure shows the co-authorship network connecting the top 25 collaborators of John R. North. A scholar is included among the top collaborators of John R. North based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. North. John R. North is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harte, N. B., et al.. (2018). The World of UCL. UCL Press eBooks. 3 indexed citations

North, John R., Shunsuke Takenaka, Annett Rozek, et al.. (2016). A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy. Journal of Biotechnology. 226. 24–34. 22 indexed citations

Aziz, Imran, et al.. (2015). Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype. Clinical Gastroenterology and Hepatology. 14(5). 696–703.e1. 84 indexed citations

Aziz, Imran, et al.. (2015). OC-067 A single-blinded study evaluating the effects of a gluten-free diet in diarrhoea-predominant irritable bowel syndrome. A34.1–A34.

Donini, Oreola, Brynmor A. Watkins, John E. Palardy, et al.. (2010). Reduced Infection and Mucositis In Chemotherapy-Treated Animals Following Innate Defense Modulation Using a Novel Drug Candidate.. Blood. 116(21). 3781–3781. 2 indexed citations

Yu, Hong, Agnieszka Kielczewska, Annett Rozek, et al.. (2009). Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide. Journal of Biological Chemistry. 284(52). 36007–36011. 66 indexed citations

Scott, Monisha G., Edie Dullaghan, Neeloffer Mookherjee, et al.. (2007). An anti-infective peptide that selectively modulates the innate immune response. Nature Biotechnology. 25(4). 465–472. 317 indexed citations

Dolphin, David, et al.. (2005). Cellular and Antitumor Activity of a New Diethylene Glycol Benzoporphyrin Derivative (Lemuteporfin)†. Photochemistry and Photobiology. 82(1). 219–219. 10 indexed citations

Kurohane, Kohta, et al.. (2001). Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Letters. 167(1). 49–56. 87 indexed citations

10.

North, John R., et al.. (2001). Augmentation of tumor immunity with ENHANZYN adjuvant following verteporfin PDT: photodynamic vaccination (PDV). Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4257. 9–9. 4 indexed citations

11.

He, Shasha, et al.. (1996). Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency. The Journal of Immunology. 156(5). 2009–2013. 36 indexed citations

12.

Spellerberg, Myfanwy B., et al.. (1990). Isolation and EBV-transformation of a minor population of normal human tonsillar B cells bearing a cold agglutinin-associated idiotope. Journal of Autoimmunity. 3(6). 759–771. 2 indexed citations

13.

Stevenson, Freda K., et al.. (1988). Use of a cross reacting anti-idiotype to identify normal counterparts of neoplastic cells.. PubMed. 30(5-6). 299–300. 5 indexed citations

14.

North, John R.. (1985). Immunosensors: Antibody-based biosensors. Trends in biotechnology. 3(7). 180–186. 97 indexed citations

15.

Morgan, Anthony J., John R. North, & M. A. Epstein. (1983). Purification and Properties of the gp340 Component of Epstein--Barr Virus Membrane Antigen in an Immunogenic Form. Journal of General Virology. 64(2). 455–460. 24 indexed citations

16.

North, John R., Andrew Morgan, & M. A. Epstein. (1980). Observations on the EB virus envelope and virus‐determined membrane antigen (MA) polypeptides. International Journal of Cancer. 26(2). 231–240. 49 indexed citations

17.

North, John R., J T Kemshead, & B A Askonas. (1977). Non-specific factor replaces T cells in an IgG response to soluble antigens.. PubMed. 33(3). 321–9. 9 indexed citations

18.

North, John R. & Brigitte A. Askonas. (1974). Analysis of affinity of monoclonal antibody responses by inhibition of plaque‐forming cells. European Journal of Immunology. 4(5). 361–366. 16 indexed citations

19.

North, John R. & A. Feinstein. (1973). Analysis of anti‐hapten foci in repopulated mouse spleens. European Journal of Immunology. 3(12). 784–789. 16 indexed citations

20.

Cooke, Anne, John R. North, & Arnold Feinstein. (1972). Antibody of Restricted Heterogeneity secreted by Spleen Fragments. Nature New Biology. 240(100). 152–154. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact